DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing
DuoBody-CD3xCD20 在临床前模型中可诱导强效的 T 细胞介导的恶性 B 细胞杀伤作用,并为皮下给药提供了机会。
期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2019.102625
Engelberts, Patrick J; Hiemstra, Ida H; de Jong, Bart; Schuurhuis, Danita H; Meesters, Joyce; Beltran Hernandez, Irati; Oostindie, Simone C; Neijssen, Joost; van den Brink, Edward N; Horbach, G Jean; Verploegen, Sandra; Labrijn, Aran F; Salcedo, Theodora; Schuurman, Janine; Parren, Paul W H I; Breij, Esther C W